Use of montelukast not associated with risk of neuropsychiatric adverse events among children: JAMA Dr. Shravani Dali28 Jan 2025 9:30 PM ISTUse of montelukast not associated with risk of neuropsychiatric adverse events among children suggests a new study published in the JAMA.Spontaneous...
Montelukast fails to alleviate symptoms among nonhospitalized COVID-19 patients: JAMA Dr. Shravani Dali4 Jan 2025 8:00 AM ISTMontelukast fails to alleviate symptoms among nonhospitalized COVID-19 patients suggets a study published in the JAMA.The effect of montelukast in...
Efficacy and Safety of Montelukast with Fexofenadine in Allergic Rhinitis Dr. Kamal Kant Kohli29 Nov 2024 11:58 AM ISTAllergic Rhinitis (AR) can be an intermittent or persistent, seasonal or perennial immunologic inflammatory condition affecting the nasal mucosa....
Practice Patterns About Management of Allergic Rhinitis: Indian HCP KAP Experience in 2024 and Preference of Fexofenadine and Montelukast Dr. Kamal Kant Kohli29 Oct 2024 10:00 AM ISTAllergic Rhinitis (AR) is the most common immune-mediated inflammatory condition affecting the nasal mucosa (1) triggered by the production of IgE...
Allergic Rhinitis and Co-morbid Asthma: All Clinician Needs to Know and Consideration of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli6 May 2024 11:30 AM ISTAllergic rhinitis (AR), a prevalent non-infectious disease condition; is an IgE-mediated response to allergens, causing symptoms like sneezing,...
Indian Guidelines Review on Allergic Rhinitis and Scope for Use of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli22 Jan 2024 11:00 AM ISTAllergic Rhinitis and Its Burden in India: Allergic rhinitis (AR) is a common inflammatory condition that affects the nasal mucosa and is...
Allergens in India and its Avoidance: Review through Indian Guidelines and Role of Fexofenadine-Montelukast Combination Dr. Kamal Kant Kohli4 Dec 2023 12:13 PM ISTAllergic rhinitis is one of the most common allergic diseases, which appears to increase in India. Risk factors, diagnosis, and AR management vary...
Allergic Rhinitis: Latest Practice Insights and Treatment Approach Dr. Kamal Kant Kohli3 Nov 2023 11:13 AM ISTUnderstanding Allergic Rhinitis(AR)Rhinitis is generally defined as inflammation of the nasal mucosa. Allergic rhinitis (AR) is a disease that affects...
CDSCO Panel approves Exemed Pharmaceutical to study Montelukast, Bilastine FDC Tablet Dr. Divya Colin14 Oct 2023 6:15 PM ISTNew Delhi: Based on the bioequivalence (BE) study report of fixed-dose combination pulmonary drug Montelukast Sodium plus Bilastine tablets presented...
Exemed Pharma Gets CDSCO Panel Nod To Study FDC of Montelukast, Bilastine Dr. Divya Colin21 July 2023 3:58 PM ISTNew Delhi: Exemed Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Allergic Rhinitis-Phenotypes, Challenges, Therapeutic Approach and Role of Montelukast Fexofenadine Combination Dr. Kamal Kant Kohli30 Jun 2023 11:45 AM ISTAtopic diseases are becoming increasingly prevalent worldwide, and allergic rhinitis (AR), an IgE-mediated inflammatory disease, is one among them....
NPPA Fixes Retail Price Of 25 Formulations, Details Susmita Roy28 March 2023 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Government of...
